Table 1 STAD patient characteristics in the TCGA database.
Characteristic | Low expression of F2R | High expression of F2R | p |
|---|---|---|---|
n | 188 | 187 | Â |
T-stage, n (%) | 0.038 | ||
 T1 | 14 (3.81%) | 5 (1.36%) |  |
 T2 | 42 (11.44%) | 38 (10.35%) |  |
 T3 | 87 (23.71%) | 81 (22.07%) |  |
 T4 | 43 (12.11%) | 57 (15.53%) |  |
N-stage, n (%) | 0.048 | ||
 N0 | 63 (17.65%) | 48 (13.45%) |  |
 N1 | 48 (13.45%) | 49 (13.73%) |  |
 N2 | 36 (10.08%) | 39 (10.92%) |  |
 N3 | 31 (8.68%) | 43 (12.04%) |  |
M-stage, n (%) | 0.847 | ||
 M0 | 165 (46.48%) | 165 (46.48%) |  |
 M1 | 13 (3.67%) | 12 (3.38%) |  |
Pathologic stage, n (%) | 0.076 | ||
 I | 34 (9.58%) | 19 (5.35%) |  |
 II | 57 (16.06%) | 54 (15.21%) |  |
 III | 65 (18.31%) | 85 (23.94%) |  |
 IV | 22 (6.20%) | 19 (5.35%) |  |
Histological grade, n (%) | 0.006 | ||
 G1 | 5 (1.37%) | 5 (1.37%) |  |
 G2 | 82 (22.40%) | 55 (15.03%) |  |
 G3 | 96 (26.23%) | 123 (33.61%) |  |
Gender, n (%) | 0.969 | ||
 Female | 67 (17.87%) | 67 (17.87%) |  |
 Male | 121 (32.27%) | 120 (32.00%) |  |
Age, n (%) | 0.81 | ||
 ≤ 70 | 120 (32.35%) | 119 (32.08%) |  |
 > 70 | 68 (18.33%) | 64 (17.25%) |  |
Tumour status (%) | 0.324 | ||
 With tumor | 43 (13.35%) | 34 (10.56%) |  |
 Tumor free | 121 (37.58%) | 124 (39.43%) |  |
Residual tumour, n (%) | 0.9 | ||
 R0 | 152 (46.20%) | 146 (44.38%) |  |
 R1 | 6 (1.82%) | 9 (2.74%) |  |
 R2 | 10 (3.04%) | 6 (1.82%) |  |
OS event, n (%) | 0.381 | ||
 Live | 147 (39.20%) | 153 (40.80%) |  |
 Death | 41 (10.93%) | 34 (9.07%) |  |
